Harvard Early Detection and Interception of Cancer Current Practice Recommendations and Novel Emerging Approaches 2025

Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care.

Through this course we will provide a comprehensive review of current cancer screening guidelines, provide guidance regarding high-risk populations and their management, educate regarding emerging technologies for early cancer detection, and provide referral pathways for complex patients.

Learning Objectives

 Identify and implement current cancer screening guidelines, with a focus on early detection and intervention for high-risk populations, and provide recommendations for managing these patients.
 Identify and establish appropriate referral pathways for patients with pre-malignant conditions requiring specialized care.
 Evaluate emerging technologies in cancer detection and assess their application for early detection of cancer.

Harvard’s “Early Detection and Interception of Cancer: Current Practice Recommendations and Novel Emerging Approaches” 2025 is best for clinicians, researchers, and healthcare professionals focused on cancer prevention, screening, and early intervention.
Here’s a detailed breakdown of who benefits most and what the program offers:
Who Should Attend

Primary care physicians and oncologists: To stay updated on best practices for cancer screening and risk management.
Genetic counselors and specialists: To understand how emerging technologies impact hereditary cancer risk assessment.
Medical researchers and public health professionals: To explore novel biomarkers, AI-driven diagnostics, and population-level strategies.
Healthcare administrators and policy makers: To evaluate integration of new screening tools into clinical workflows and health systems.
Advanced practice providers (NPs, PAs): To enhance their role in early detection and patient education.

What You’ll Learn

Current screening guidelines for major cancers (e.g., breast, colorectal, lung).
Management of high-risk populations, including those with genetic predispositions.
Emerging technologies such as liquid biopsies, AI-powered imaging, and molecular diagnostics.
Strategies for clinical integration of new tools and approaches into routine care.

 
+ Topics:
Monday, September 15, 2025

9:00-9:15 am Welcome and Kick Off Ben Ebert; Sapna Syngal; Betsy O’Donnell
9:15-9:45 am Whole Body Imaging for Screening and Early Detection of Cancer – Promises and Pitfalls Michael Rosenthal
9:45-10:00 am Management of DCIS (Ductal Carcinoma in SITU) and Other Breast Cancer Precursors Emily Gatof
10:00-10:15 am Genetics 101: Identification and Genetic Testing for Inherited Cancer Predisposition Elizabeth Kearns
10:15-10:30 am Management of Hereditary Cancer Predisposition in Your Practice Huma Rana
10:30-10:45 am Screening and Early Detection of Gynecologic Malignancies Colleen Feltmate
10:45-11:00 am Q&A Colleen Feltmate; Emily Gatof; Huma Rana; Elizabeth Kearns
11:00-11:15 am Break
11:15-11:30 am Screening and Early Detection of Dermatologic Malignancies Nicole Leboeuf
11:30-11:45 am Unexplained Cytopenia – When to Consider Clonal Hematopoiesis and Myelodysplastic Syndrome (MDS) Lachelle Weeks
11:45 am-12:00 pm Intercepting Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma Irene Ghobrial
12:00-12:15 pm Q&A Nicole Leboeuf; Lachelle Weeks; Irene Ghobrial
12:15-1:00 pm Lunch Break
1:00-1:15 pm Precursors to Head & Neck, Oral Cancers, and Management Glenn Hanna
1:15-1:30 pm Management of IPMNs, Barrett’s Esophagus and other Precursors to GI Cancer Nicolette Rodriguez
1:30-1:45 pm Screening and Early Detection of Lung Cancer Jacob Sands
1:45-2:00 pm Screening and Early Detection of Genitourinary Cancers Bicky Thapa
2:00-2:15 pm Q&A Nicolette Rodriguez; Jacob Sands; Glenn Hanna; Bicky Thapa
2:15-2:30 pm Break
2:30-2:45 pm Multi-Cancer Early Detection Tests – Ready for Prime Time? Betsy O’Donnell
2:45-3:00 pm Promoting Equity in Screening and Early Detection Timothy Rebbeck
3:00-3:15 pm Patient Experience with Multi-Cancer Early Detection Testing Karen Burns White
3:15-3:30 pm Panel Discussion: Looking to the Future of Early Detection and Interception Betsy O’Donnell; Timothy Rebbeck; Karen Burns White; Sapna Syngal
3:30-4:30 pm Networking Reception